Ambu AS (STU:547A)
€ 15.73 -1.58 (-9.13%) Market Cap: 4.19 Bil Enterprise Value: 4.18 Bil PE Ratio: 75.98 PB Ratio: 6.11 GF Score: 90/100

Q2 2023 Ambu A/S Earnings Call Transcript

May 03, 2023 / 07:00AM GMT
Release Date Price: €13.86 (+2.48%)
Britt Meelby Jensen;S;CEO
Ambu A

/-

Good morning, everyone, and welcome to this Q2 '22-'23 results call with the Ambu. My name is Britt Meelby Jensen, I'm the CEO of Ambu, and I'm joined today by Thomas Frederik Schmidt, our Chief Financial Officer.

So the agenda for this meeting is that I'll go through an update on the business. I'll hand over to Thomas to take you through the financial results. And then we will, as usual, finish off with the Q&A session.

But let's dive straight into the results. So in Q2, we delivered an organic growth of 4%. And if we look at the reported growth, this was 6%. And overall for the first 6 months of our fiscal year we delivered also 4% organically and 8% reported growth. Our EBIT margin is in line with our expect expectation, reporting 3.9% on the quarter and 4.9% on the full half year period.

If we look at the market, and let me put a few comments on the health care market in general. What we do see out in the hospitals where activity level is a main driver for our business, we do see the activity level

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot